Michael Barbella, Managing Editor05.12.22
Conformis Inc. has welcomed Gary P. Fischetti to its Board of Directors. He replaces Richard Meelia, who retired from the board immediately before its May 4 annual meeting.
Fischetti currently chairs the Orchid Orthopedic Solutions board and is a member of Extremity Medical's board. He worked for 35 years at Johnson & Johnson (including at its DePuy Synthes orthopedic subsidiaries), where he served in positions of increasing responsibility in multiple businesses, with both domestic and worldwide responsibilities. This included serving as the company Group Chairman – NA Medical Devices for Johnson & Johnson’s medical device business. He previously also served as the worldwide Company Group Chairman for the DePuy Synthes companies, which included the Joint Reconstruction, Spine, Trauma, CMF, and Powertools businesses. Prior to that, he served as the worldwide Company Group Chairman for all the DePuy Orthopaedic businesses and the Codman franchise, and as the Worldwide President of DePuy Spine.
Fischetti earned a BSBA degree in finance from Villanova University and an M.B.A. from Rutgers University.
“On behalf of everyone at Conformis, I want to thank Rich Meelia for his leadership and service to our board over the past seven years. We have benefitted a great deal from his experience and perspective. We wish him every success in his future endeavors," CEO Mark Augusti said. "At the same time, we are excited about the opportunity to have someone with Gary Fischetti’s orthopedic industry experience serve as part of our Board of Directors. I believe that his deep commercial experience in the orthopedics industry, combined with his strategic planning and organizational skills will be a great asset for Conformis.”
Conformis is a medical technology company with a product portfolio that offers fully personalized solutions through its Image-to-Implant Platinum Services Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Fischetti currently chairs the Orchid Orthopedic Solutions board and is a member of Extremity Medical's board. He worked for 35 years at Johnson & Johnson (including at its DePuy Synthes orthopedic subsidiaries), where he served in positions of increasing responsibility in multiple businesses, with both domestic and worldwide responsibilities. This included serving as the company Group Chairman – NA Medical Devices for Johnson & Johnson’s medical device business. He previously also served as the worldwide Company Group Chairman for the DePuy Synthes companies, which included the Joint Reconstruction, Spine, Trauma, CMF, and Powertools businesses. Prior to that, he served as the worldwide Company Group Chairman for all the DePuy Orthopaedic businesses and the Codman franchise, and as the Worldwide President of DePuy Spine.
Fischetti earned a BSBA degree in finance from Villanova University and an M.B.A. from Rutgers University.
“On behalf of everyone at Conformis, I want to thank Rich Meelia for his leadership and service to our board over the past seven years. We have benefitted a great deal from his experience and perspective. We wish him every success in his future endeavors," CEO Mark Augusti said. "At the same time, we are excited about the opportunity to have someone with Gary Fischetti’s orthopedic industry experience serve as part of our Board of Directors. I believe that his deep commercial experience in the orthopedics industry, combined with his strategic planning and organizational skills will be a great asset for Conformis.”
Conformis is a medical technology company with a product portfolio that offers fully personalized solutions through its Image-to-Implant Platinum Services Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.